Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (noting a discrepancy with the request metadata which listed "Standard BioTools Inc.") on November 5, 2019. The filing serves to report the company's financial results for the third fiscal quarter of 2019. The registrant is incorporated in Delaware and its common stock trades on the Nasdaq Global Select Market under the symbol FLDM.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the press release furnished as Exhibit 99.1, which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It solely indicates that the company issued a press release reporting Q3 2019 results.
Guidance, Outlook, and Risks
The text does not contain management commentary, guidance, outlook, or specific risk factors. It includes a standard legal disclaimer stating that the information furnished in this report and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into future filings unless expressly stated.
Investor Verification Checklist
- Verify the correct registrant name: The filing is for Fluidigm Corporation, not Standard BioTools Inc.
- Locate and review Exhibit 99.1 (the press release) to obtain actual financial figures for Q3 2019.
- Confirm the trading symbol FLDM on the Nasdaq Global Select Market.
- Note that the financial data in this specific 8-K text is not "filed" for liability purposes under Section 18 of the Exchange Act.